Evidence map›Paper›PMID 40244356›Full record

ArticleInsights into imaging2025

A deep learning model based on self-supervised learning for identifying subtypes of proliferative hepatocellular carcinoma from dynamic contrast-enhanced MRI.

Hui Qu, Shuairan Zhang, Xuedan Li, Yuan Miao, Yuxi Han, Ronghui Ju, Xiaoyu Cui, Yiling Li

Abstract read
In one paragraph

Article in Insights into imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hui Qu *College of Medicine and Biological Information Engineering, Northeastern University, Shenyang, PR China.
Shuairan Zhang *Department of Gastroenterology, The First Hospital of China Medical University, Shenyang, PR China.
Xuedan LiDepartment of Radiology, The First Hospital of China Medical University, Shenyang, PR China.
Yuan MiaoDepartment of Pathology, The College of Basic Medical Science and the First Hospital of China Medical University, Shenyang, PR China.
Yuxi HanDepartment of Gastroenterology, The First Hospital of China Medical University, Shenyang, PR China.
Ronghui JuDepartment of Radiology, The People's Hospital of Liaoning Province, Shenyang, PR China. d8299@lnph.com.
Xiaoyu CuiCollege of Medicine and Biological Information Engineering, Northeastern University, Shenyang, PR China. cuixy@bmie.neu.edu.cn.
Yiling LiDepartment of Gastroenterology, The First Hospital of China Medical University, Shenyang, PR China. lyl-72@163.com.ORCID http://orcid.org/0000-0003-3209-8105

Funding

Artificial Intelligence Field Technology Innovation Project (Applied Basic Resea) 2023-JH26/10300009Key Laboratory of Medical Imaging Science and Technology Systems, Natural Science Foundation of Liaoning Province 2022-MS-105Medical and engineering joint fund of Liaoning Province 2022-YGJC-76Noncommunicable Chronic Diseases-National Science and Technology Major Project 2023ZD0508700Scientific Research Fund of Liaoning Provincial Education Department LJKMZ20221167
6 · The paper itself

Abstract

objectivesThis study employs dynamic contrast-enhanced MRI (DCE-MRI) to noninvasively predict the proliferative subtype of hepatocellular carcinoma (HCC). This subtype is marked by high tumor proliferation and aggressive clinical behavior. We developed a deep learning prediction model that employs a dynamic radiomics workflow and self-supervised learning (SSL). The model analyzes temporal and spatial patterns in DCE-MRI data to identify the proliferative subtype efficiently and accurately. Our goal is to improve diagnostic precision and guide personalized treatment planning.

methodsThis retrospective study included 381 HCC patiephonnts who underwent curative resection at two medical centers. The cohort was divided into the training (n = 220), internal (n = 93), and external (n = 68) test sets. A DL model was developed using DCE-MRI of the primary tumor. Class activation mapping was used to interpret HCC proliferation in HCC.

resultsThe pHCC-SSL model performed well in predicting HCC proliferation, with a training set AUC) of 1.00, an internal test set AUC of 0.91, and an external test set AUC of 0.94. Without SSL pre-training, the AUC for internal and external testing decreased to 0.81 and 0.80, respectively. The predictive performance of the derived model was superior to that of the current single-sequence model.

conclusionsThe pHCC-SSL model employs dynamic radiomics and a two-stage training approach to efficiently predict HCC proliferation from multi-sequence DCE-MRI, surpassing traditional single-stage models in accuracy and speed. CRITICAL RELEVANCE STATEMENT: Our study introduces the pHCC-SSL model, a self-supervised deep learning approach using DCE-MRI that enhances the diagnostic accuracy of HCC subtypes, significantly advancing clinical radiology by enabling personalized treatment strategies. KEY POINTS: The proposed model enables noninvasive identification of HCC with high proliferation and aggressive behavior. SSL improves lesion differentiation by reducing redundancy and enhancing feature diversity. Dynamic feature extraction captures vascular infiltration, aiding preoperative metastasis risk assessment.

Indexed as

Deep learningDynamic contrast-enhanced MRIHepatocellular carcinomaPrediction modelSelf-supervised learning

Identifiers

PMID40244356
PMCPMC12006648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.